
 
 
 
 
 
 
 
 
   
 1. An isolated nucleic acid sequence encoding epothilone B hydroxylase of SEQ ID NO: 2 or a mutant thereof, wherein said mutant comprises at least one amino acid substitution at an amino acid position seleted from the group consisting of GLU31, ARG67, ARG88, ILE92, ALA93, VAL106, ILE130, ALA140, MET176, PHE190, GLU231, SER294, PHE237, and ILE365 of SEQ ID NO: 2, and wherein said mutant has epothilone B hydroxylase activity. 
 
     
 2. The isolated nucleic acid sequence of  claim 1  comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, 30, 32, 34, 60, 62, 64, 66, 68, 72 and 74. 
 
     
 3. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at GLU31 of SEQ ID NO:2. 
 
     
 4. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid sequence substitution at ARG67 of SEQ ID NO:2. 
 
     
 5. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at ARG88 of SEQ ID NO:2. 
 
     
 6. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at ILE92 of SEQ ID NO:2. 
 
     
 7. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at ALA93 of SEQ ID NO:2. 
 
     
 8. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at VAL106 of SEQ ID NO:2. 
 
     
 9. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at ILE130 of SEQ ID NO:2. 
 
     
 10. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at ALA140 of SEQ ID NO:2. 
 
     
 11. The isolated nucleic avid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at MET176 of SEQ ID NO:2. 
 
     
 12. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at PHE190 of SEQ ID NO:2. 
 
     
 13. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at GLU231 of SEQ ID NO:2. 
 
     
 14. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at SER294 of SEQ ID NO:2. 
 
     
 15. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at PHE237 of SBQ ID NO:2. 
 
     
 16. The isolated nucleic acid sequence of  claim 1  wherein said at least one mutation comprises an amino acid substitution at ILE365 of SEQ ID NO:2. 
 
     
 17. A vector comprising the isolated nucleic acid sequence of  claim 1 . 
 
     
 18. An isolated host cell comprising the vector of  claim 17 . 
 
     
 19. A method for producing a recombinant microorganism which hydroxylate epothilone B, said method comprising transfecting a microorganism with the vector of  claim 17 . 
 
     
 20. A recombinant microorganism produced by the method of  claim 19 . 
 
     
 21. The recombinant microorganism of  claim 20  wherein said microorganism expresses a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, 30, 32, 34, 60, 62, 64, 66, 68, 72 and 74. 
 
   
 
 
 
 
 
 
 
 
